Innovent Biologics, Inc, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune,...
GeneDx, a leader in delivering improved health outcomes through genomic insights, announced the appointment of Bryan Dechairo as Chief Operating Officer, effective immediately. In...
Immedica Pharma AB, a leading global rare disease company, and Marinus Pharmaceuticals, Inc, a pharmaceutical company committed to improving the lives of patients with...
Exicure, Inc, has announced the signing of a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc. on December 24, 2024, aimed at the acquisition...
